114 related articles for article (PubMed ID: 10416534)
1. HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era.
Manfredi R; Nanetti A; Ferri M; Chiodo F
AIDS; 1999 Jul; 13(10):1274-6. PubMed ID: 10416534
[No Abstract] [Full Text] [Related]
2. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals.
Tacconelli E; Tumbarello M; de Gaetano K; Cauda R; Ortona L
Clin Infect Dis; 1998 Oct; 27(4):901-2. PubMed ID: 9798056
[No Abstract] [Full Text] [Related]
4. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy.
Grulich AE
AIDS Read; 2000 Jun; 10(6):341-6. PubMed ID: 10881365
[TBL] [Abstract][Full Text] [Related]
5. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era.
Tumbarello M; Tacconelli E; Donati KG; Citton R; Leone F; Spanu T; Cauda R
J Acquir Immune Defic Syndr; 2000 Feb; 23(2):145-51. PubMed ID: 10737429
[TBL] [Abstract][Full Text] [Related]
6. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era.
Martin-Iguacel R; Ahlström MG; Touma M; Engsig FN; Stærke NB; Stærkind M; Obel N; Rasmussen LD
J Infect; 2017 Sep; 75(3):263-273. PubMed ID: 28579301
[TBL] [Abstract][Full Text] [Related]
7. Decline of infectious skin manifestations in the era of highly active antiretroviral therapy.
Hengge UR; Franz B; Goos M
AIDS; 2000 May; 14(8):1069-70. PubMed ID: 10853995
[No Abstract] [Full Text] [Related]
8. Highly active antiretroviral therapy.
Drobniewski F; Eltringham I
Lancet; 1998 Apr; 351(9108):1059-60. PubMed ID: 9546534
[No Abstract] [Full Text] [Related]
9. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy.
Tumbarello M; Tacconelli E; de Gaetano Donati K; Cauda R
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):208-9. PubMed ID: 10048911
[No Abstract] [Full Text] [Related]
10. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
11. Natural history of HIV infection in the era of combination antiretroviral therapy.
Moore RD; Chaisson RE
AIDS; 1999 Oct; 13(14):1933-42. PubMed ID: 10513653
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
[TBL] [Abstract][Full Text] [Related]
13. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy.
Jacobson MA; French M
AIDS; 1998; 12 Suppl A():S157-63. PubMed ID: 9632998
[TBL] [Abstract][Full Text] [Related]
14. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
15. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy.
van Elden LJ; Walenkamp AM; Lipovsky MM; Reiss P; Meis JF; de Marie S; Dankert J; Hoepelman AI
AIDS; 2000 Dec; 14(17):2787-8. PubMed ID: 11125898
[No Abstract] [Full Text] [Related]
16. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
[No Abstract] [Full Text] [Related]
17. HIV and tuberculosis--a "cursed duo" in the HAART era.
Londhey VA
J Assoc Physicians India; 2009 Oct; 57():681-2. PubMed ID: 20329423
[No Abstract] [Full Text] [Related]
18. Exacerbation of skin mycobacterial lesions under highly active antiretroviral therapy in an HIV-infected patient.
Sotto A; Guillot B; Dandurand M; Jourdan J
AIDS; 1999 Sep; 13(13):1790-1. PubMed ID: 10509588
[No Abstract] [Full Text] [Related]
19. Opportunistic infections occurring during highly active antiretroviral treatment.
Michelet C; Arvieux C; François C; Besnier JM; Rogez JP; Breux JP; Souala F; Allavena C; Raffi F; Garre M; Cartier F
AIDS; 1998 Oct; 12(14):1815-22. PubMed ID: 9792382
[TBL] [Abstract][Full Text] [Related]
20. CMV.
Posit Aware; 2000; 11(1):24. PubMed ID: 11366342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
